John Slof

669 total citations
34 papers, 493 citations indexed

About

John Slof is a scholar working on Economics and Econometrics, Accounting and Psychiatry and Mental health. According to data from OpenAlex, John Slof has authored 34 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 8 papers in Accounting and 7 papers in Psychiatry and Mental health. Recurrent topics in John Slof's work include Botulinum Toxin and Related Neurological Disorders (4 papers), Glioma Diagnosis and Treatment (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). John Slof is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (4 papers), Glioma Diagnosis and Treatment (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). John Slof collaborates with scholars based in Spain, United Kingdom and Palestinian Territory. John Slof's co-authors include Josep M. Argilés, Jordi Galván, Ricardo Díez Valle, Josep María Argilés-Bosch, Camila Arza, Margarita Torrent, Carlos Vila, Khaldoon Albitar, Aída Ribera and Xavier Badı́a and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Cardiology.

In The Last Decade

John Slof

31 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Slof Spain 12 139 108 107 86 80 34 493
Suyun Chen China 17 34 0.2× 42 0.4× 84 0.8× 39 0.5× 18 0.2× 68 684
Hyunsuk Peter Suh South Korea 17 105 0.8× 8 0.1× 162 1.5× 45 0.5× 67 0.8× 97 1.1k
Christophe Bonnet Belgium 18 192 1.4× 94 0.9× 35 0.3× 12 0.1× 15 0.2× 73 963
Michael J. Petersen United States 13 10 0.1× 168 1.6× 18 0.2× 113 1.3× 70 0.9× 27 642
Volker Zimmermann Germany 12 13 0.1× 133 1.2× 32 0.3× 70 0.8× 19 0.2× 49 707
Lei Fang China 19 14 0.1× 35 0.3× 105 1.0× 32 0.4× 30 0.4× 99 1.2k
Haiying Pan United States 14 74 0.5× 26 0.2× 13 0.1× 57 0.7× 67 0.8× 26 526
William Stein United States 10 101 0.7× 9 0.1× 22 0.2× 51 0.6× 25 0.3× 21 649
Weilin Zhao China 17 49 0.4× 6 0.1× 43 0.4× 28 0.3× 8 0.1× 39 666
Jiro Honda United States 10 10 0.1× 23 0.2× 30 0.3× 28 0.3× 15 0.2× 43 386

Countries citing papers authored by John Slof

Since Specialization
Citations

This map shows the geographic impact of John Slof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Slof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Slof more than expected).

Fields of papers citing papers by John Slof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Slof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Slof. The network helps show where John Slof may publish in the future.

Co-authorship network of co-authors of John Slof

This figure shows the co-authorship network connecting the top 25 collaborators of John Slof. A scholar is included among the top collaborators of John Slof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Slof. John Slof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribera, Aída, Ignacio Aznar‐Lou, John Slof, et al.. (2024). Costs during the first year after stroke by degree of functional disability: A societal perspective. European Stroke Journal. 10(2). 513–523.
2.
Salvat‐Plana, Mercè, John Slof, Natàlia Pérez de la Ossa, et al.. (2024). Care-related quality of life of informal caregivers of stroke survivors: Cross-sectional analysis of a randomized clinical trial. PLoS ONE. 19(10). e0307930–e0307930. 3 indexed citations
3.
Slof, John, et al.. (2023). The mediation effect of audit committee quality and internal audit function quality on the firm size–financial reporting quality nexus. Journal of Applied Accounting Research. 24(5). 839–858. 8 indexed citations
4.
Ribera, Aída, John Slof, Ignacio Ferreira‐González, et al.. (2017). The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement. The European Journal of Health Economics. 19(7). 945–956. 12 indexed citations
5.
Slof, John, Ricardo Díez Valle, & Jordi Galván. (2015). Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery. SHILAP Revista de lepidopterología. 30(3). 163–168. 34 indexed citations
6.
7.
Ribera, Aída, John Slof, Rut Andrea, et al.. (2014). Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: Cost–utility and its determinants. International Journal of Cardiology. 182. 321–328. 25 indexed citations
8.
9.
Slof, John, Ricardo Díez Valle, & Jordi Galván. (2014). Análisis coste-efectividad de la cirugía del glioma maligno guiada por fluorescencia con ácido 5-aminolevulínico. Neurología. 30(3). 163–168. 32 indexed citations
10.
11.
12.
Slof, John, et al.. (2012). Sativex® in multiple sclerosis spasticity: a cost–effectiveness model. Expert Review of Pharmacoeconomics & Outcomes Research. 12(4). 439–441. 24 indexed citations
13.
Slof, John. (2012). Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the ‘Act when Mild’ Study. Applied Health Economics and Health Policy. 10(3). 201–215. 8 indexed citations
14.
Slof, John, et al.. (2009). ¿Es comparable la información contable antes y después de las NIIF?. Revista de Contabilidad y Tributación CEF. 125–140. 1 indexed citations
15.
Slof, John, et al.. (2009). [Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis].. PubMed. 24(3). 147–53. 2 indexed citations
16.
Martı́nez, Alfredo & John Slof. (2008). Análisis coste-eficacia de las combinaciones fijas de prostaglandinas/prostamida para el tratamiento del glaucoma. Archivos de la Sociedad Española de Oftalmología. 83(10). 595–600. 3 indexed citations
17.
18.
Slof, John, et al.. (2005). Zoledronic acid versus pamidronate: cost minimisation in bone metastasis. Journal of Medical Economics. 8(1-4). 1–12. 3 indexed citations
19.
Argilés, Josep M. & John Slof. (2000). New Opportunities for Farm Accounting. SSRN Electronic Journal. 17 indexed citations
20.
Slof, John, et al.. (1997). Disponibilidad y defectos en la presentación de las cuentas anuales en el Registro Mercantil. Técnica contable. 49(581). 381–394. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suyun Chen Breakdown of academic impact, for papers by Hyunsuk Peter Suh Breakdown of academic impact, for papers by Christophe Bonnet Breakdown of academic impact, for papers by Michael J. Petersen Breakdown of academic impact, for papers by Volker Zimmermann Breakdown of academic impact, for papers by Lei Fang Breakdown of academic impact, for papers by Haiying Pan Breakdown of academic impact, for papers by William Stein Breakdown of academic impact, for papers by Weilin Zhao Breakdown of academic impact, for papers by Jiro Honda
Rankless by CCL
2026